The Global Antidepressant Medicine Sales share analysis in 2023 shows varied performance across countries. Germany, Spain, and Italy hold the highest sales value, though Italy experienced a slight decline. Australia and South Korea demonstrate significant positive growth, with South Korea showing the highest increase. Conversely, many European countries, such as Greece and Denmark, faced declines, reflecting market saturation or reduced demand.
Future trends to watch include the continued growth in South Korea and Australia, possibly driven by increased mental health awareness and healthcare initiatives. Conversely, European markets might face continued stagnation unless innovative approaches stimulate demand.
Top countries in Antidepressant Medicine Sales Share by Country (Million US Dollars)
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 27.48 | 2023 | +2.48% | +0.96% | View data |
| 2 | 2 Spain | 21.05 | 2023 | -1.56% | +1.8% | View data |
| 3 | 3 Italy | 13.25 | 2023 | -1.49% | -1.02% | View data |
| 4 | 4 Australia | 13.15 | 2023 | +1.46% | +5.02% | View data |
| 5 | 5 South Korea | 9.34 | 2023 | +4.4% | +9.11% | View data |
| 6 | 6 Belgium | 3.93 | 2023 | -1.32% | -2.17% | View data |
| 7 | 7 Greece | 2.78 | 2023 | -9.2% | -6.46% | View data |
| 8 | 8 Czech Republic | 2.57 | 2023 | +4.54% | +4.48% | View data |
| 9 | 9 Austria | 2.12 | 2023 | -7.42% | -5.54% | View data |
| 10 | 10 Finland | 1.4 | 2023 | 0% | +4.03% | View data |
